| # | Drug | Count |
|---|---|---|
| 0 | METOPROLOL | 5 |
| 1 | METOPROLOL TARTRATE | 5 |
| 2 | ADALIMUMAB | 4 |
| 3 | METOPROLOL TARTRATE INJECTION | 4 |
| 4 | ASPIRIN | 3 |
| 5 | ASPIRIN 325 MG | 3 |
| 6 | ASPIRIN 81 MG | 3 |
| 7 | ERGOCALCIFEROL | 3 |
| 8 | ACETAMINOPHEN | 2 |
| 9 | CYCLOSPORINE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SENNA LAXATIVE | 1 | 0.0008 |
| 1 | PSYLLIUM HUSK | 1 | 0.0007 |
| 2 | BACILLUS CALMETTE-GUERIN | 1 | 0.0006 |
| 3 | LEVALBUTEROL HYDROCHLORIDE | 1 | 0.0003 |
| 4 | ISAVUCONAZONIUM SULFATE | 1 | 0.0003 |
| 5 | ZANUBRUTINIB | 1 | 0.0002 |
| 6 | IRBESARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0002 |
| 7 | TRETINOIN | 1 | 0.0001 |
| 8 | ICOSAPENT ETHYL | 1 | 0.0001 |
| 9 | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 1 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 2 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 4 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 6 | Soluble Guanylate Cyclase Stimulator [EPC] | 1 | 0.0000 |
| 7 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 8 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |